# Indoor Daylight Photodynamic Therapy is an Effective, First-line Treatment for AK, But Its Feasibility is Limited by the Time Required for the Illumination (2 Hours). Our Objective Was to Evaluate the Efficacy of Idl-PDT With an Illumination Time of 1 Hour Versus 2 Hours in the Treatment of Scalp AK

> **NCT07290959** · NA · COMPLETED · sponsor: **San Salvatore Hospital of L'Aquila** · enrollment: 55 (actual)

## Conditions studied

- Actinic Keratosis (AK)

## Interventions

- **OTHER:** We conducted an intra-patient, comparative study of idl-PDT with two illumination durations, 1 hour vs. 2 hours, using methyl aminolevulinate and a white LED light for the treatment of scalp AK.

## Key facts

- **NCT ID:** NCT07290959
- **Lead sponsor:** San Salvatore Hospital of L'Aquila
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-01-02
- **Primary completion:** 2025-07-01
- **Final completion:** 2025-07-15
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2025-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07290959

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07290959, "Indoor Daylight Photodynamic Therapy is an Effective, First-line Treatment for AK, But Its Feasibility is Limited by the Time Required for the Illumination (2 Hours). Our Objective Was to Evaluate the Efficacy of Idl-PDT With an Illumination Time of 1 Hour Versus 2 Hours in the Treatment of Scalp AK". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07290959. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*